Production (Stage)
Beam Therapeutics Inc.
BEAM
$16.83
-$0.41-2.38%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.22B | 850.74M | 925.76M | 1.01B | 1.09B |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 27.66M | 27.41M | 19.78M | 21.28M | 27.16M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 1.25B | 878.15M | 945.53M | 1.03B | 1.12B |
|
|||||
Total Current Assets | 1.25B | 878.15M | 945.53M | 1.03B | 1.12B |
Net Property, Plant & Equipment | 211.79M | 216.28M | 218.21M | 224.35M | 229.95M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 7.52M | 9.40M | 7.63M | 7.48M | 8.14M |
Total Assets | 1.47B | 1.10B | 1.17B | 1.26B | 1.36B |
|
|||||
Total Accounts Payable | 7.70M | 3.87M | 3.81M | 4.43M | 2.79M |
Total Accrued Expenses | 22.32M | 36.13M | 25.47M | 20.26M | 14.48M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 13.21M | 13.47M | 12.94M | 12.64M | 12.18M |
Total Finance Division Other Current Liabilities | 98.32M | 128.59M | 124.03M | 140.01M | 157.76M |
Total Other Current Liabilities | 98.32M | 128.59M | 124.03M | 140.01M | 157.76M |
Total Current Liabilities | 141.55M | 182.07M | 166.24M | 177.33M | 187.22M |
|
|||||
Total Current Liabilities | 141.55M | 182.07M | 166.24M | 177.33M | 187.22M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 144.92M | 147.96M | 149.13M | 152.60M | 155.94M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 57.32M | 40.26M | 64.68M | 77.24M | 103.15M |
Total Liabilities | 343.78M | 370.28M | 380.05M | 407.17M | 446.31M |
|
|||||
Common Stock & APIC | 2.80B | 2.30B | 2.27B | 2.23B | 2.20B |
Retained Earnings | -1.68B | -1.57B | -1.48B | -1.38B | -1.29B |
Treasury Stock & Other | 160.00K | 679.00K | 1.76M | -1.11M | -921.00K |
Total Common Equity | 1.12B | 733.55M | 791.32M | 854.09M | 913.49M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 1.12B | 733.55M | 791.32M | 854.09M | 913.49M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 1.12B | 733.55M | 791.32M | 854.09M | 913.49M |
|